PBK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14974 | T702 | Sugiyama | PPP1R12A MBS MYPT1 | RKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRSTRTREQ |
| O15371 | T46 | Sugiyama | EIF3D EIF3S7 | RDMPyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGG |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43390 | T142 | Sugiyama | HNRNPR HNRPR | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQPG |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43615 | T198 | Sugiyama | TIMM44 MIMT44 TIM44 | ALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKF |
| O43663 | T481 | EPSD | PRC1 | EMLyGsAPRtPsKRRGLAPNtPGKARKLNTttMsNAtANss |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | T139 | Sugiyama | SYNCRIP HNRPQ NSAP1 | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQPs |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60739 | T45 | Sugiyama | EIF1B | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| O60828 | T219 | Sugiyama | PQBP1 NPW38 JM26 | EELDPMDPSsysDAPRGTWstGLPKRNEAKTGADttAAGPL |
| O75385 | S469 | SIGNOR|PSP | ULK1 KIAA0722 | QsPtQFQtPRSSAIRRsGstsPLGFARAsPsPPAHAEHGGV |
| O75385 | S495 | SIGNOR|PSP | ULK1 KIAA0722 | RAsPsPPAHAEHGGVLARKMsLGGGRPYTPSPQVGTIPERP |
| O75385 | S533 | SIGNOR|PSP | ULK1 KIAA0722 | ERPGWSGtPsPQGAEMRGGRsPRPGssAPEHsPRTSGLGCR |
| O75533 | T203 | Sugiyama | SF3B1 SAP155 | VVNGAAAsQPPsKRKRRWDQtADQtPGAtPKKLssWDQAEt |
| O75821 | T174 | Sugiyama | EIF3G EIF3S4 | IVSCRICKGDHWTTRCPYKDtLGPMQKELAEQLGLstGEKE |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O95365 | T461 | Sugiyama | ZBTB7A FBI1 LRF ZBTB7 ZNF857A | QQCGAAFAHNYDLKNHMRVHtGLRPYQCDSCCKTFVRSDHL |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05412 | S63 | EPSD|PSP | JUN | ADPVGSLKPHLRAKNsDLLtsPDVGLLKLAsPELERLIIQS |
| P05412 | S73 | EPSD|PSP | JUN | LRAKNsDLLtsPDVGLLKLAsPELERLIIQSSNGHItttPt |
| P05455 | T120 | Sugiyama | SSB | VTDEyKNDVKNRsVYIKGFPtDAtLDDIKEWLEDKGQVLNI |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06748 | T279 | Sugiyama | NPM1 NPM | GsLPKVEAKFINyVKNCFRMtDQEAIQDLWQWRKsL_____ |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07711 | T332 | Sugiyama | CTSL CTSL1 | VKMAKDRRNHCGIAsAAsyPtV___________________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08758 | T111 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | yDAyELKHALKGAGTNEKVLtEIIAsRtPEELRAIKQVyEE |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P11142 | S85 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | NtVFDAKRLIGRRFDDAVVQsDMKHWPFMVVNDAGRPKVQV |
| P11142 | T222 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFI |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P12277 | T322 | Sugiyama | CKB CKBB | LGKHEKFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRL |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P12956 | S306 | Sugiyama | XRCC6 G22P1 | IKLYRETNEPVKTKTRtFNtstGGLLLPsDtKRSQIYGSRQ |
| P12956 | T305 | Sugiyama | XRCC6 G22P1 | PIKLYRETNEPVKTKTRtFNtstGGLLLPsDtKRSQIYGSR |
| P12956 | T307 | Sugiyama | XRCC6 G22P1 | KLYRETNEPVKTKTRtFNtstGGLLLPsDtKRSQIYGSRQI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P18124 | T170 | Sugiyama | RPL7 | VNELIyKRGYGKINKKRIALtDNALIARSLGKyGIICMEDL |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P21108 | S8 | Sugiyama | PRPS1L1 PRPS3 PRPSL | _____________MPNIKIFsGssHQDLSQKIADRLGLELG |
| P23284 | T81 | Sugiyama | PPIB CYPB | IFGLFGKTVPKTVDNFVALAtGEKGFGYKNSKFHRVIKDFM |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26641 | S25 | Sugiyama | EEF1G EF1G PRO1608 | TLyTyPENWRAFKALIAAQYsGAQVRVLsAPPHFHFGQtNR |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T18 | Sugiyama | RPL12 | ___MPPKFDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLs |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | T69 | Sugiyama | PEBP1 PBP PEBP | RPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWHHFLV |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P36578 | S66 | Sugiyama | RPL4 RPL1 | KNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHR |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T287 | Sugiyama | RPL4 RPL1 | WRKAAsLKsNyNLPMHKMINtDLsRILKsPEIQRALRAPRK |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P41091 | T115 | Sugiyama | EIF2S3 EIF2G | SCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRHVSFVDC |
| P41567 | T45 | Sugiyama | EIF1 SUI1 | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46087 | T409 | Sugiyama | NOP2 NOL1 NSUN1 | LDMCCAPGGKTSYMAQLMKNtGVILANDANAERLKSVVGNL |
| P46776 | T95 | Sugiyama | RPL27A | LDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRsGyyKVLGKG |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49711 | T374 | Sugiyama | CTCF | SMCDYASVEVSKLKRHIRSHtGERPFQCSLCSYASRDTYKL |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50990 | T286 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | MNFsKGEENLMDAQVKAIADtGANVVVtGGKVADMALHYAN |
| P50990 | T293 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | ENLMDAQVKAIADtGANVVVtGGKVADMALHYANKYNIMLV |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P52209 | S126 | Sugiyama | PGD PGDH | YRDTTRRCRDLKAKGILFVGsGVsGGEEGARyGPSLMPGGN |
| P52747 | T352 | Sugiyama | ZNF143 SBF STAF | EGCGRSFTTSNIRKVHVRTHtGERPYyCTEPGCGRAFASAT |
| P52747 | Y358 | Sugiyama | ZNF143 SBF STAF | FTTSNIRKVHVRTHtGERPYyCTEPGCGRAFASATNYKNHV |
| P54652 | T225 | Sugiyama | HSPA2 | GGTFDVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLA |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55072 | T249 | Sugiyama | VCP HEL-220 HEL-S-70 | LFKAIGVKPPRGILLyGPPGtGKTLIARAVANETGAFFFLI |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P56270 | S302 | Sugiyama | MAZ ZNF801 | EMCGKAFRDVYHLNRHKLSHsDEKPyQCPVCQQRFKRKDRM |
| P57721 | S158 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | AsQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T173 | Sugiyama | TPI1 TPI | DNVKDWSKVVLAyEPVWAIGtGKtATPQQAQEVHEKLRGWL |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60484 | S380 | SIGNOR | PTEN MMAC1 TEP1 | SSsTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQI |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60891 | S8 | Sugiyama | PRPS1 | _____________MPNIKIFsGssHQDLSQKIADRLGLELG |
| P61254 | S31 | Sugiyama | RPL26 | RsKNRKRHFNAPsHIRRKIMssPLSKELRQKYNVRSMPIRK |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P62191 | T230 | Sugiyama | PSMC1 | yyEEMGIKPPKGVILyGPPGtGKTLLAKAVANQTsATFLRV |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62753 | T34 | Sugiyama | RPS6 OK/SW-cl.2 | KLIEVDDERKLRtFyEKRMAtEVAADALGEEWKGYVVRIsG |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | T21 | Sugiyama | RPS28 | MDTSRVQPIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRs |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63173 | T44 | Sugiyama | RPL38 | KIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPGL |
| P63173 | T48 | Sugiyama | RPL38 | NKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPGLAVKE |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | S11 | SIGNOR|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P78371 | T242 | Sugiyama | CCT2 99D8.1 CCTB | KKIGVNQPKRIENAKILIANtGMDtDKIKIFGsRVRVDstA |
| P81274 | T457 | GPS6|SIGNOR|EPSD|PSP | GPSM2 LGN | IAKPSAKLLFVNRLKGKKYKtNSSTKVLQDASNSIDHRIPN |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00839 | T549 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GtNtIMDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEI |
| Q00839 | T554 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | MDKMMVAGFKKQMADtGKLNtLLQRAPQCLGKFIEIAARKK |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02878 | T118 | Sugiyama | RPL6 TXREB1 | GDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQHVR |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | S32 | SIGNOR|EPSD|PSP | PRDX1 PAGA PAGB TDPX2 | APNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVC |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13642 | T39 | Sugiyama | FHL1 SLIM1 | YVQKDGHHCCLKCFDKFCANtCVECRKPIGADSKEVHYKNR |
| Q14119 | S197 | Sugiyama | VEZF1 DB1 ZNF161 | EMCGKAFRDVYHLNRHKLSHsDEKPFECPICNQRFKRKDRM |
| Q14152 | T1372 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKASWRAEKDREsLRRTKNEtDEDGWttVRR__________ |
| Q14592 | S275 | Sugiyama | ZNF460 ZNF272 | SECGRTFNRGSHLTRHQRVHsGEKPFVCNECGKAFTYRSNF |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15365 | S126 | Sugiyama | PCBP1 | ATQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAI |
| Q15366 | S126 | Sugiyama | PCBP2 | AsQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAI |
| Q16881 | T311 | Sugiyama | TXNRD1 GRIM12 KDRF | KATNNKGKEKIYSAERFLIAtGERPRyLGIPGDKEyCIsSD |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6PKG0 | T747 | Sugiyama | LARP1 KIAA0731 LARP | PPVDPNQEVPPGPPRFQQVPtDALANKLFGAPEPstIARsL |
| Q6QNY0 | T16 | Sugiyama | BLOC1S3 BLOS3 | _____MASQGRRRRPLRRPEtVVPGEAtEtDsERsAsssEE |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q8IWL2 | S16 | Sugiyama | SFTPA1 COLEC4 PSAP SFTP1 SFTPA SFTPA1B | _____MWLCPLALNLILMAAsGAVCEVKDVCVGSPGIPGTP |
| Q8IZP0 | T114 | Sugiyama | ABI1 SSH3BP1 | SQTVDIHKEKVARREIGILTtNKNTSRTHKIIAPANMERPV |
| Q8N1G4 | T27 | Sugiyama | LRRC47 KIAA1185 | SESWPELELAERERRRELLLtGPGLEERVRAAGGQLPPRLF |
| Q8NBJ7 | T260 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | SPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMGNtPD |
| Q8TEQ6 | S847 | Sugiyama | GEMIN5 | LKKEPPKEKPETLIKKRKARsLLPLstsLDHRSKEELHQDC |
| Q8TEQ6 | S852 | Sugiyama | GEMIN5 | PKEKPETLIKKRKARsLLPLstsLDHRSKEELHQDCLVLAT |
| Q8WU90 | T345 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | DsVsVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDEN |
| Q8WVC0 | T477 | Sugiyama | LEO1 RDL | FDVYKAPLQGDHNHLFIRQGtGLQGQAVFKTKLTFRPHstD |
| Q96KB5 | S110 | Sugiyama | PBK TOPK | KsLHHPNIVGyRAFtEANDGsLCLAMEYGGEKSLNDLIEER |
| Q96KB5 | S19 | Sugiyama | PBK TOPK | __MEGISNFKtPsKLsEKKKsVLCstPtINIPAsPFMQKLG |
| Q96KB5 | S32 | Sugiyama | PBK TOPK | KLsEKKKsVLCstPtINIPAsPFMQKLGFGTGVNVYLMKRS |
| Q96KB5 | S59 | Sugiyama | PBK TOPK | GFGTGVNVYLMKRSPRGLsHsPWAVKKINPICNDHyRsVYQ |
| Q96KB5 | T104 | Sugiyama | PBK TOPK | DEAKILKsLHHPNIVGyRAFtEANDGsLCLAMEYGGEKSLN |
| Q96KB5 | T24 | Sugiyama | PBK TOPK | ISNFKtPsKLsEKKKsVLCstPtINIPAsPFMQKLGFGTGV |
| Q96KB5 | T301 | Sugiyama | PBK TOPK | INMEELDESYQKVIELFsVCtNEDPKDRPsAAHIVEALEtD |
| Q96KB5 | T320 | Sugiyama | PBK TOPK | CtNEDPKDRPsAAHIVEALEtDV__________________ |
| Q96S44 | S250 | EPSD|PSP | TP53RK C20orf64 PRPK | KKARPVLKKLDEVRLRGRKRsMVG_________________ |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BUJ2 | T507 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | CLNRLIQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRK |
| Q9BX40 | T343 | Sugiyama | LSM14B C20orf40 FAM61B RAP55B | ssELKTSSRRTTWAEERKLNtEtFGVsGRFLRGRSSRGGFR |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9BYW2 | T1316 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | TRDYWQGNGYWDPRSGRPPGtGVVYDRTQGQVPDSLTDDRE |
| Q9NVS9 | T111 | Sugiyama | PNPO | KPSARMLLLKGFGKDGFRFFtNFESRKGKELDSNPFASLVF |
| Q9NVS9 | T238 | Sugiyama | PNPO | FWQGQTNRLHDRIVFRRGLPtGDsPLGPMTHRGEEDWLyER |
| Q9NYB9 | T114 | Sugiyama | ABI2 ARGBPIA | SQTVDIHKEKVARREIGILTtNKNTSRTHKIIAPANLERPV |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UKX7 | T54 | Sugiyama | NUP50 NPAP60L PRO1146 | VLKNRAIKKAKRRNVGFEsDtGGAFKGFKGLVVPSGGGRFs |
| Q9ULF5 | T87 | Sugiyama | SLC39A10 KIAA1265 ZIP10 | LFERYGENGRLSFFGLEKLLtNLGLGERKVVEINHEDLGHD |
| Q9UNX3 | S31 | Sugiyama | RPL26L1 RPL26P1 | RsKNRKRHFNAPSHVRRKIMssPLSKELRQKYNVRSMPIRK |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ80 | T377 | Sugiyama | PA2G4 EBP1 | LLQssAsRKtQKKKKKKAsKtAENAtsGEtLEENEAGD___ |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| RNA Polymerase II Transcription | R-HSA-73857 | 1.049735e-09 | 8.979 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.733220e-10 | 9.059 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.110223e-08 | 7.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.235945e-06 | 5.651 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.321189e-06 | 5.274 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.412335e-05 | 4.850 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.894988e-05 | 4.409 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.783421e-05 | 4.320 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.783768e-05 | 4.109 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.842284e-05 | 4.165 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.958815e-05 | 4.099 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.944881e-05 | 4.100 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.203957e-04 | 3.919 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.537755e-04 | 3.813 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.919417e-04 | 3.717 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.275440e-04 | 3.643 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.265778e-04 | 3.645 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.757518e-04 | 3.559 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.806882e-04 | 3.552 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.903818e-04 | 3.537 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.615185e-04 | 3.442 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.685531e-04 | 3.433 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.545847e-04 | 3.450 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.084795e-04 | 3.389 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.153905e-04 | 3.382 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.253370e-04 | 3.371 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.564797e-04 | 3.341 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.474646e-04 | 3.262 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.044902e-04 | 3.219 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.452993e-04 | 3.190 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.665942e-04 | 3.176 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.809628e-04 | 3.107 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.534352e-04 | 3.069 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.102673e-04 | 3.041 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.059979e-03 | 2.975 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.065182e-03 | 2.973 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.877534e-04 | 3.005 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.055360e-03 | 2.977 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.603734e-04 | 3.018 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.071790e-03 | 2.970 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.043642e-03 | 2.981 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.210416e-03 | 2.917 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.210416e-03 | 2.917 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.176519e-03 | 2.929 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.126642e-03 | 2.948 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.169404e-03 | 2.932 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.263265e-03 | 2.899 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.448339e-03 | 2.839 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.501403e-03 | 2.824 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.520688e-03 | 2.818 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.596722e-03 | 2.797 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.862050e-03 | 2.730 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.851512e-03 | 2.732 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.851512e-03 | 2.732 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.796294e-03 | 2.746 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.862701e-03 | 2.730 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.796294e-03 | 2.746 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.177858e-03 | 2.662 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.413011e-03 | 2.617 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.413011e-03 | 2.617 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.485534e-03 | 2.605 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.491476e-03 | 2.604 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.690866e-03 | 2.570 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.790278e-03 | 2.554 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.969081e-03 | 2.527 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.933772e-03 | 2.533 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.063498e-03 | 2.514 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.584362e-03 | 2.446 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.739454e-03 | 2.427 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.721270e-03 | 2.429 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.843134e-03 | 2.415 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.843134e-03 | 2.415 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.003780e-03 | 2.398 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.929288e-03 | 2.406 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.173955e-03 | 2.379 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.489025e-03 | 2.348 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.489025e-03 | 2.348 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.398455e-03 | 2.357 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.629781e-03 | 2.334 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.988049e-03 | 2.302 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.131394e-03 | 2.290 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.856689e-03 | 2.314 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.988049e-03 | 2.302 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.312605e-03 | 2.275 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.426538e-03 | 2.265 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.503817e-03 | 2.259 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.558607e-03 | 2.255 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.725192e-03 | 2.242 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.958109e-03 | 2.225 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.309345e-03 | 2.200 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.354426e-03 | 2.197 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 6.480357e-03 | 2.188 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.492560e-03 | 2.188 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.429494e-03 | 2.129 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.048164e-03 | 2.094 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.269950e-03 | 2.082 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.301992e-03 | 2.081 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.315778e-03 | 2.080 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.324648e-03 | 2.080 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.647357e-03 | 2.063 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.869738e-03 | 2.006 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.485646e-03 | 2.023 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.267544e-03 | 2.033 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.928593e-03 | 2.003 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.147828e-02 | 1.940 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.244976e-02 | 1.905 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.244976e-02 | 1.905 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.216576e-02 | 1.915 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.191128e-02 | 1.924 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.168659e-02 | 1.932 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.244976e-02 | 1.905 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.276785e-02 | 1.894 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.345036e-02 | 1.871 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.351540e-02 | 1.869 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.538025e-02 | 1.813 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.589719e-02 | 1.799 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.632878e-02 | 1.787 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.636104e-02 | 1.786 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.643438e-02 | 1.784 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.709213e-02 | 1.767 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.813154e-02 | 1.742 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.653233e-02 | 1.782 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 1.813154e-02 | 1.742 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.881215e-02 | 1.726 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.339138e-02 | 1.631 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.262367e-02 | 1.645 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.398641e-02 | 1.620 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.262367e-02 | 1.645 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.337592e-02 | 1.631 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.231103e-02 | 1.651 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.265132e-02 | 1.645 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.265132e-02 | 1.645 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.398641e-02 | 1.620 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.194795e-02 | 1.659 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.429371e-02 | 1.615 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.605538e-02 | 1.584 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.631496e-02 | 1.580 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.634737e-02 | 1.579 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.634737e-02 | 1.579 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.670071e-02 | 1.573 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.688600e-02 | 1.570 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.841877e-02 | 1.546 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.841877e-02 | 1.546 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.921412e-02 | 1.534 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.232817e-02 | 1.490 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.323553e-02 | 1.478 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.308161e-02 | 1.480 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.328844e-02 | 1.478 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.182025e-02 | 1.497 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.257062e-02 | 1.487 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.457021e-02 | 1.461 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.537845e-02 | 1.451 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.537845e-02 | 1.451 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.538686e-02 | 1.451 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.593288e-02 | 1.445 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.634116e-02 | 1.440 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 3.872714e-02 | 1.412 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.051076e-02 | 1.392 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.051076e-02 | 1.392 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.046306e-02 | 1.393 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.046306e-02 | 1.393 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.919893e-02 | 1.407 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.348691e-02 | 1.362 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.179558e-02 | 1.379 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.051076e-02 | 1.392 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.437492e-02 | 1.353 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.433988e-02 | 1.353 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.348691e-02 | 1.362 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.413919e-02 | 1.355 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.953426e-02 | 1.403 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.578220e-02 | 1.339 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.783623e-02 | 1.320 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.959912e-02 | 1.305 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.959912e-02 | 1.305 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.998006e-02 | 1.301 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.162948e-02 | 1.287 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.227903e-02 | 1.282 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.454087e-02 | 1.263 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.457244e-02 | 1.263 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.520172e-02 | 1.258 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.601560e-02 | 1.252 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.015500e-02 | 1.221 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.015500e-02 | 1.221 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.096344e-02 | 1.215 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 7.096690e-02 | 1.149 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.096690e-02 | 1.149 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.510561e-02 | 1.186 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.787873e-02 | 1.168 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.411769e-02 | 1.193 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.338207e-02 | 1.198 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 7.096690e-02 | 1.149 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.411769e-02 | 1.193 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.215552e-02 | 1.142 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.415464e-02 | 1.193 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.343422e-02 | 1.134 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.365147e-02 | 1.133 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.404572e-02 | 1.131 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 7.595675e-02 | 1.119 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 7.595675e-02 | 1.119 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 7.595675e-02 | 1.119 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 7.595675e-02 | 1.119 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 7.595675e-02 | 1.119 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.117467e-01 | 0.952 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.117467e-01 | 0.952 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.117467e-01 | 0.952 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.792276e-01 | 0.747 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.792276e-01 | 0.747 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.235136e-02 | 1.084 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.110234e-01 | 0.676 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.110234e-01 | 0.676 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.110234e-01 | 0.676 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.110234e-01 | 0.676 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 9.424795e-02 | 1.026 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.066001e-01 | 0.972 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.066001e-01 | 0.972 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.066001e-01 | 0.972 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.066001e-01 | 0.972 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.415894e-01 | 0.617 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.415894e-01 | 0.617 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.415894e-01 | 0.617 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.415894e-01 | 0.617 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.193548e-01 | 0.923 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.324624e-01 | 0.878 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.324624e-01 | 0.878 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.324624e-01 | 0.878 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.324624e-01 | 0.878 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.324624e-01 | 0.878 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.324624e-01 | 0.878 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.324624e-01 | 0.878 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.709730e-01 | 0.567 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.709730e-01 | 0.567 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 2.709730e-01 | 0.567 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 2.709730e-01 | 0.567 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.785431e-02 | 1.109 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.458767e-01 | 0.836 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.458767e-01 | 0.836 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.595543e-01 | 0.797 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.992199e-01 | 0.524 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 2.992199e-01 | 0.524 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.992199e-01 | 0.524 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 2.992199e-01 | 0.524 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.734548e-01 | 0.761 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.734548e-01 | 0.761 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.581885e-02 | 1.120 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.263740e-01 | 0.486 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.263740e-01 | 0.486 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.263740e-01 | 0.486 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.263740e-01 | 0.486 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.017762e-01 | 0.695 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.524775e-01 | 0.453 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.524775e-01 | 0.453 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.524775e-01 | 0.453 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.524775e-01 | 0.453 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.524775e-01 | 0.453 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.524775e-01 | 0.453 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.524775e-01 | 0.453 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.716482e-01 | 0.765 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.450684e-01 | 0.611 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.775710e-01 | 0.423 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.775710e-01 | 0.423 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.813601e-01 | 0.741 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.813601e-01 | 0.741 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.380716e-01 | 0.860 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.012019e-01 | 0.696 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.012019e-01 | 0.696 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.016935e-01 | 0.396 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.016935e-01 | 0.396 | 0 | 0 |
| OADH complex synthesizes glutaryl-CoA from 2-OA | R-HSA-9858328 | 4.016935e-01 | 0.396 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.016935e-01 | 0.396 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.113078e-01 | 0.675 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.287835e-01 | 0.890 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.287835e-01 | 0.890 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.318311e-01 | 0.635 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.031571e-01 | 0.518 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.031571e-01 | 0.518 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.031571e-01 | 0.518 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.248825e-01 | 0.372 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.422259e-01 | 0.616 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.985158e-01 | 0.702 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.147332e-01 | 0.668 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.471742e-01 | 0.350 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.471742e-01 | 0.350 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.738124e-01 | 0.563 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.980833e-01 | 0.703 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.844408e-01 | 0.546 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.844408e-01 | 0.546 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.604160e-01 | 0.443 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.188767e-01 | 0.660 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.057882e-01 | 0.515 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.057882e-01 | 0.515 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.057882e-01 | 0.515 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.271954e-01 | 0.485 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.022033e-01 | 0.396 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.485937e-01 | 0.458 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.088999e-01 | 0.510 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.088999e-01 | 0.510 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.846678e-01 | 0.546 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.354119e-01 | 0.474 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.227156e-01 | 0.491 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.885776e-01 | 0.411 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.974037e-01 | 0.401 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.149883e-01 | 0.382 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.422259e-01 | 0.616 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.598057e-01 | 0.796 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.598057e-01 | 0.796 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.409132e-01 | 0.467 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.324624e-01 | 0.878 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.535466e-01 | 0.452 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.904426e-01 | 0.537 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.049380e-01 | 0.688 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.912153e-01 | 0.718 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.716482e-01 | 0.765 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.076763e-01 | 0.390 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.441223e-01 | 0.841 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.422259e-01 | 0.616 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 9.424795e-02 | 1.026 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.017762e-01 | 0.695 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.248825e-01 | 0.372 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.598057e-01 | 0.796 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.386348e-01 | 0.858 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 8.235136e-02 | 1.084 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.193548e-01 | 0.923 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.193548e-01 | 0.923 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 1.324624e-01 | 0.878 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.734548e-01 | 0.761 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.875404e-01 | 0.727 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.256750e-01 | 0.901 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.017762e-01 | 0.695 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.267766e-02 | 1.033 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.524775e-01 | 0.453 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.048193e-01 | 0.980 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.176429e-01 | 0.929 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.319608e-01 | 0.479 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.293337e-01 | 0.367 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.344829e-01 | 0.871 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.434969e-01 | 0.843 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.598057e-01 | 0.796 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.548922e-01 | 0.594 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.524251e-01 | 0.817 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.524251e-01 | 0.817 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.699196e-01 | 0.432 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.065780e-01 | 0.685 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.403037e-01 | 0.619 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.005359e-01 | 0.522 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.880665e-01 | 0.411 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.066001e-01 | 0.972 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.415894e-01 | 0.617 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.458767e-01 | 0.836 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.875404e-01 | 0.727 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.875404e-01 | 0.727 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.263740e-01 | 0.486 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.380716e-01 | 0.860 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.248825e-01 | 0.372 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.471742e-01 | 0.350 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.471742e-01 | 0.350 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.229753e-01 | 0.652 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.462395e-01 | 0.461 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.951025e-01 | 0.530 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.873463e-01 | 0.542 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.267766e-02 | 1.033 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.775710e-01 | 0.423 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.065780e-01 | 0.685 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.074106e-01 | 0.512 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.708782e-01 | 0.431 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.734548e-01 | 0.761 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.912153e-01 | 0.718 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.604160e-01 | 0.443 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.744768e-01 | 0.427 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.153793e-01 | 0.382 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.305694e-01 | 0.637 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.664594e-02 | 1.116 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.526947e-01 | 0.597 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.471742e-01 | 0.350 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.378998e-01 | 0.471 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.861561e-01 | 0.413 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.118704e-01 | 0.674 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.426531e-01 | 0.354 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.354119e-01 | 0.474 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.378998e-01 | 0.471 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.846678e-01 | 0.546 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.980833e-01 | 0.703 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.003517e-01 | 0.998 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.287322e-01 | 0.641 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.117467e-01 | 0.952 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.461524e-01 | 0.835 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 1.792276e-01 | 0.747 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.193548e-01 | 0.923 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.193548e-01 | 0.923 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.324624e-01 | 0.878 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.709730e-01 | 0.567 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.709730e-01 | 0.567 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.458767e-01 | 0.836 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.017762e-01 | 0.695 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.524775e-01 | 0.453 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.775710e-01 | 0.423 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.177323e-02 | 1.037 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 4.016935e-01 | 0.396 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.016935e-01 | 0.396 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.016935e-01 | 0.396 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.287835e-01 | 0.890 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 4.248825e-01 | 0.372 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.650963e-01 | 0.782 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.526947e-01 | 0.597 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.526947e-01 | 0.597 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.065780e-01 | 0.685 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.471742e-01 | 0.350 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.471742e-01 | 0.350 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.744768e-01 | 0.427 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.913416e-01 | 0.536 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.913416e-01 | 0.536 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.485937e-01 | 0.458 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.293337e-01 | 0.367 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.062086e-01 | 0.391 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.436632e-01 | 0.464 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.006111e-01 | 0.397 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.450684e-01 | 0.611 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.256750e-01 | 0.901 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.997976e-01 | 0.523 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.638262e-01 | 0.579 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.886659e-01 | 0.540 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.235331e-01 | 0.490 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.403037e-01 | 0.619 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.451763e-01 | 0.462 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.516477e-02 | 1.070 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.524775e-01 | 0.453 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.016935e-01 | 0.396 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.637810e-01 | 0.579 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.637810e-01 | 0.579 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.637810e-01 | 0.579 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.997976e-01 | 0.523 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.382633e-01 | 0.471 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.336373e-01 | 0.631 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.812479e-01 | 0.551 | 0 | 0 |
| Translation | R-HSA-72766 | 2.489360e-01 | 0.604 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.263740e-01 | 0.486 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.016935e-01 | 0.396 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.016935e-01 | 0.396 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.113078e-01 | 0.675 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.318311e-01 | 0.635 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.319608e-01 | 0.479 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.885776e-01 | 0.411 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.225481e-01 | 0.374 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.729367e-01 | 0.428 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.383824e-01 | 0.358 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.994643e-01 | 0.524 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.938070e-01 | 0.405 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.285112e-01 | 0.368 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.175794e-01 | 0.930 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.586804e-02 | 1.066 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.285112e-01 | 0.368 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.177323e-02 | 1.037 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.307959e-01 | 0.480 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.687610e-01 | 0.433 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.012019e-01 | 0.696 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.733525e-02 | 1.012 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.798650e-01 | 0.553 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.319608e-01 | 0.479 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.351516e-01 | 0.475 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.884096e-01 | 0.411 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.022033e-01 | 0.396 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.793704e-01 | 0.554 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.904426e-01 | 0.537 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.694294e-01 | 0.771 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.089604e-01 | 0.680 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.117467e-01 | 0.952 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.792276e-01 | 0.747 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.110234e-01 | 0.676 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.415894e-01 | 0.617 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 2.415894e-01 | 0.617 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.193548e-01 | 0.923 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.709730e-01 | 0.567 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.709730e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.992199e-01 | 0.524 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.734548e-01 | 0.761 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.161293e-01 | 0.665 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.111482e-01 | 0.954 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.305694e-01 | 0.637 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.775710e-01 | 0.423 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.775710e-01 | 0.423 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.775710e-01 | 0.423 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 4.016935e-01 | 0.396 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.471742e-01 | 0.350 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.158477e-01 | 0.381 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 4.426531e-01 | 0.354 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.480438e-01 | 0.830 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.780622e-02 | 1.109 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.780622e-02 | 1.109 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.140334e-01 | 0.943 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.562380e-01 | 0.806 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.951025e-01 | 0.530 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.805370e-01 | 0.420 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.799188e-01 | 0.745 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.057859e-01 | 0.392 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.111482e-01 | 0.954 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.709730e-01 | 0.567 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.462395e-01 | 0.461 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.462395e-01 | 0.461 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 2.652846e-01 | 0.576 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.911149e-01 | 0.408 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 9.949402e-02 | 1.002 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 3.744768e-01 | 0.427 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.572161e-01 | 0.590 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.215214e-01 | 0.655 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.207657e-02 | 1.086 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.738124e-01 | 0.563 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.001057e-01 | 0.523 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.500753e-02 | 1.071 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.263872e-01 | 0.898 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.337963e-01 | 0.631 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.426437e-01 | 0.846 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.521025e-01 | 0.453 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.305694e-01 | 0.637 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.033048e-01 | 0.692 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.521025e-01 | 0.453 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.521025e-01 | 0.453 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.324624e-01 | 0.878 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.176271e-01 | 0.498 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.318311e-01 | 0.635 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.145926e-01 | 0.941 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.933580e-01 | 0.714 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.736891e-01 | 0.760 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.461524e-01 | 0.835 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.792276e-01 | 0.747 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.415894e-01 | 0.617 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.193548e-01 | 0.923 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.709730e-01 | 0.567 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.992199e-01 | 0.524 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.263740e-01 | 0.486 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.305694e-01 | 0.637 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.620921e-01 | 0.790 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.775710e-01 | 0.423 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.775710e-01 | 0.423 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 2.741399e-01 | 0.562 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.404531e-01 | 0.852 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.248825e-01 | 0.372 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.422259e-01 | 0.616 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.844408e-01 | 0.546 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.844408e-01 | 0.546 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.951025e-01 | 0.530 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.182646e-01 | 0.497 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.797344e-01 | 0.421 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.738980e-01 | 0.562 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.980833e-01 | 0.703 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.158477e-01 | 0.381 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.734548e-01 | 0.761 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.844408e-01 | 0.546 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.426531e-01 | 0.354 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.058195e-01 | 0.515 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.536955e-01 | 0.813 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.696898e-01 | 0.569 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.396252e-01 | 0.620 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.005359e-01 | 0.522 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.826937e-01 | 0.738 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.357739e-01 | 0.867 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.415894e-01 | 0.617 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.415894e-01 | 0.617 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.193548e-01 | 0.923 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.709730e-01 | 0.567 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.734548e-01 | 0.761 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.087277e-01 | 0.964 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.263740e-01 | 0.486 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.017762e-01 | 0.695 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.111482e-01 | 0.954 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.775710e-01 | 0.423 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.775710e-01 | 0.423 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.775710e-01 | 0.423 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.595999e-01 | 0.586 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.012019e-01 | 0.696 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.012019e-01 | 0.696 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.741399e-01 | 0.562 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 4.248825e-01 | 0.372 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.248825e-01 | 0.372 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.632270e-01 | 0.580 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.592695e-01 | 0.445 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.039795e-01 | 0.517 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.324572e-01 | 0.364 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.411391e-01 | 0.355 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.342131e-01 | 0.362 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.886659e-01 | 0.540 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.462395e-01 | 0.461 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.536955e-01 | 0.813 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 4.158477e-01 | 0.381 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.170857e-01 | 0.931 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.170857e-01 | 0.931 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.513262e-01 | 0.820 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.040379e-01 | 0.394 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.709730e-01 | 0.567 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.267766e-02 | 1.033 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.434969e-01 | 0.843 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.225481e-01 | 0.374 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.088820e-01 | 0.963 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.723598e-01 | 0.565 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.263740e-01 | 0.486 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.017762e-01 | 0.695 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.111482e-01 | 0.954 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.886659e-01 | 0.540 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.031571e-01 | 0.518 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.471742e-01 | 0.350 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.065330e-01 | 0.685 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.524251e-01 | 0.817 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.409858e-01 | 0.467 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.951025e-01 | 0.530 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.173679e-01 | 0.663 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.263740e-01 | 0.486 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.017762e-01 | 0.695 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.444959e-02 | 1.025 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.175692e-01 | 0.498 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.974037e-01 | 0.401 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.885776e-01 | 0.411 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.775710e-01 | 0.423 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.215214e-01 | 0.655 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.744768e-01 | 0.427 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.278367e-01 | 0.893 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.666256e-01 | 0.574 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.016935e-01 | 0.396 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.458767e-01 | 0.836 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.886659e-01 | 0.540 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.225481e-01 | 0.374 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.305694e-01 | 0.637 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.319608e-01 | 0.479 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.471742e-01 | 0.350 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.629375e-01 | 0.788 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.001057e-01 | 0.523 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.158477e-01 | 0.381 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.550512e-01 | 0.810 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.177191e-01 | 0.498 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.768838e-01 | 0.752 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.111920e-01 | 0.954 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.187204e-01 | 0.925 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.095127e-01 | 0.679 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.826700e-01 | 0.738 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.491962e-01 | 0.348 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.491962e-01 | 0.348 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.514177e-01 | 0.345 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.534107e-01 | 0.344 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.536041e-01 | 0.343 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.557985e-01 | 0.341 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.557985e-01 | 0.341 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.557985e-01 | 0.341 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.557985e-01 | 0.341 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.557985e-01 | 0.341 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.557985e-01 | 0.341 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.557985e-01 | 0.341 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.635475e-01 | 0.334 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.635475e-01 | 0.334 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.635475e-01 | 0.334 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.669340e-01 | 0.331 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.686031e-01 | 0.329 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.686031e-01 | 0.329 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 4.686031e-01 | 0.329 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.686031e-01 | 0.329 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.686031e-01 | 0.329 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 4.686031e-01 | 0.329 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 4.686031e-01 | 0.329 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.686031e-01 | 0.329 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.686031e-01 | 0.329 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.686031e-01 | 0.329 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 4.686031e-01 | 0.329 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.686031e-01 | 0.329 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.686031e-01 | 0.329 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.686031e-01 | 0.329 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.687635e-01 | 0.329 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.687635e-01 | 0.329 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.687635e-01 | 0.329 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.736014e-01 | 0.325 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 4.736014e-01 | 0.325 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.815423e-01 | 0.317 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.815423e-01 | 0.317 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.815423e-01 | 0.317 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.815423e-01 | 0.317 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.815423e-01 | 0.317 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.815423e-01 | 0.317 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.815423e-01 | 0.317 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.817138e-01 | 0.317 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.836889e-01 | 0.315 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.836889e-01 | 0.315 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.892027e-01 | 0.311 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.892027e-01 | 0.311 | 0 | 0 |
| OGDH complex synthesizes succinyl-CoA from 2-OG | R-HSA-9853506 | 4.892027e-01 | 0.311 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 4.892027e-01 | 0.311 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.892027e-01 | 0.311 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 4.892027e-01 | 0.311 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 4.892027e-01 | 0.311 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.892027e-01 | 0.311 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 4.892027e-01 | 0.311 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 4.892027e-01 | 0.311 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 4.892027e-01 | 0.311 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.892027e-01 | 0.311 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.892027e-01 | 0.311 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.892027e-01 | 0.311 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.934441e-01 | 0.307 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.934441e-01 | 0.307 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.941299e-01 | 0.306 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.941299e-01 | 0.306 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.941299e-01 | 0.306 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.951805e-01 | 0.305 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.979686e-01 | 0.303 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.006279e-01 | 0.300 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.006279e-01 | 0.300 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.032254e-01 | 0.298 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.032254e-01 | 0.298 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.058702e-01 | 0.296 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.065218e-01 | 0.295 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.065218e-01 | 0.295 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.065218e-01 | 0.295 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.065218e-01 | 0.295 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.087651e-01 | 0.293 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.089079e-01 | 0.293 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.090049e-01 | 0.293 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 5.090049e-01 | 0.293 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.090049e-01 | 0.293 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.090049e-01 | 0.293 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.090049e-01 | 0.293 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.090049e-01 | 0.293 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.090049e-01 | 0.293 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.090049e-01 | 0.293 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 5.090049e-01 | 0.293 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.090049e-01 | 0.293 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 5.090049e-01 | 0.293 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 5.090049e-01 | 0.293 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 5.090049e-01 | 0.293 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.090049e-01 | 0.293 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.090049e-01 | 0.293 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.090049e-01 | 0.293 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.090049e-01 | 0.293 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.090049e-01 | 0.293 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.104269e-01 | 0.292 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.129088e-01 | 0.290 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.131805e-01 | 0.290 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.187144e-01 | 0.285 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.187144e-01 | 0.285 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.187144e-01 | 0.285 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.187144e-01 | 0.285 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.232693e-01 | 0.281 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.280406e-01 | 0.277 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.280406e-01 | 0.277 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.280406e-01 | 0.277 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.280406e-01 | 0.277 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.280406e-01 | 0.277 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.280406e-01 | 0.277 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.280406e-01 | 0.277 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.280406e-01 | 0.277 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.280406e-01 | 0.277 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.280406e-01 | 0.277 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.280406e-01 | 0.277 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.280406e-01 | 0.277 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.319695e-01 | 0.274 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.333646e-01 | 0.273 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.413819e-01 | 0.266 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.424894e-01 | 0.266 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.424894e-01 | 0.266 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.424894e-01 | 0.266 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.463394e-01 | 0.263 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.463394e-01 | 0.263 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.463394e-01 | 0.263 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.463394e-01 | 0.263 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.463394e-01 | 0.263 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.463394e-01 | 0.263 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.463394e-01 | 0.263 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.463394e-01 | 0.263 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.463394e-01 | 0.263 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.463394e-01 | 0.263 | 0 | 0 |
| Carnitine synthesis | R-HSA-71262 | 5.463394e-01 | 0.263 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.493283e-01 | 0.260 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.506039e-01 | 0.259 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.540670e-01 | 0.256 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.540670e-01 | 0.256 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.540670e-01 | 0.256 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.540670e-01 | 0.256 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.540670e-01 | 0.256 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.540670e-01 | 0.256 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.540670e-01 | 0.256 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.540670e-01 | 0.256 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.540670e-01 | 0.256 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.572020e-01 | 0.254 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.639298e-01 | 0.249 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 5.639298e-01 | 0.249 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.639298e-01 | 0.249 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.639298e-01 | 0.249 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 5.639298e-01 | 0.249 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 5.639298e-01 | 0.249 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 5.639298e-01 | 0.249 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.639298e-01 | 0.249 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.639298e-01 | 0.249 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 5.639298e-01 | 0.249 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.639298e-01 | 0.249 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.639298e-01 | 0.249 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.639298e-01 | 0.249 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.654358e-01 | 0.248 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 5.654358e-01 | 0.248 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.654358e-01 | 0.248 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.654358e-01 | 0.248 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.654358e-01 | 0.248 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.667145e-01 | 0.247 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.687932e-01 | 0.245 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.699138e-01 | 0.244 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.765945e-01 | 0.239 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.765945e-01 | 0.239 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.765945e-01 | 0.239 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.765945e-01 | 0.239 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.765945e-01 | 0.239 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.765945e-01 | 0.239 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.777161e-01 | 0.238 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.803706e-01 | 0.236 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.803706e-01 | 0.236 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.808391e-01 | 0.236 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 5.808391e-01 | 0.236 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 5.808391e-01 | 0.236 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.808391e-01 | 0.236 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.808391e-01 | 0.236 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.808391e-01 | 0.236 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.808391e-01 | 0.236 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.875422e-01 | 0.231 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.875422e-01 | 0.231 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.879376e-01 | 0.231 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.902906e-01 | 0.229 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.970938e-01 | 0.224 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.970938e-01 | 0.224 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.970938e-01 | 0.224 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 5.970938e-01 | 0.224 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.970938e-01 | 0.224 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 5.970938e-01 | 0.224 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 5.970938e-01 | 0.224 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.970938e-01 | 0.224 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.970938e-01 | 0.224 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.970938e-01 | 0.224 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.970938e-01 | 0.224 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.970938e-01 | 0.224 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.973287e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.982787e-01 | 0.223 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.982787e-01 | 0.223 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.982787e-01 | 0.223 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.982787e-01 | 0.223 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.035763e-01 | 0.219 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.037780e-01 | 0.219 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.037780e-01 | 0.219 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.088037e-01 | 0.216 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.088037e-01 | 0.216 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.088037e-01 | 0.216 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.101526e-01 | 0.215 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.124521e-01 | 0.213 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.127191e-01 | 0.213 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.127191e-01 | 0.213 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.127191e-01 | 0.213 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.127191e-01 | 0.213 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.127191e-01 | 0.213 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.127191e-01 | 0.213 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.127191e-01 | 0.213 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.127191e-01 | 0.213 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 6.127191e-01 | 0.213 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.127191e-01 | 0.213 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.127191e-01 | 0.213 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.127191e-01 | 0.213 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.127191e-01 | 0.213 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.127191e-01 | 0.213 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.127191e-01 | 0.213 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.166137e-01 | 0.210 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.173919e-01 | 0.209 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.191176e-01 | 0.208 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.191176e-01 | 0.208 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.191176e-01 | 0.208 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.191176e-01 | 0.208 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.191176e-01 | 0.208 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.277393e-01 | 0.202 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.277393e-01 | 0.202 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.277393e-01 | 0.202 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.277393e-01 | 0.202 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.277393e-01 | 0.202 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.277393e-01 | 0.202 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.277393e-01 | 0.202 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.277393e-01 | 0.202 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.277393e-01 | 0.202 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.277393e-01 | 0.202 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.287546e-01 | 0.202 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.287546e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.287546e-01 | 0.202 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.292208e-01 | 0.201 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.292208e-01 | 0.201 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.292208e-01 | 0.201 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.292208e-01 | 0.201 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.293959e-01 | 0.201 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.343998e-01 | 0.198 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.368349e-01 | 0.196 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.391143e-01 | 0.194 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.391143e-01 | 0.194 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.397144e-01 | 0.194 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.402467e-01 | 0.194 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.421779e-01 | 0.192 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 6.421779e-01 | 0.192 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.421779e-01 | 0.192 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.421779e-01 | 0.192 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.421779e-01 | 0.192 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.421779e-01 | 0.192 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.421779e-01 | 0.192 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 6.421779e-01 | 0.192 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.421779e-01 | 0.192 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.421779e-01 | 0.192 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.421779e-01 | 0.192 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.421779e-01 | 0.192 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.487990e-01 | 0.188 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.487990e-01 | 0.188 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.487990e-01 | 0.188 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.523063e-01 | 0.186 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.526243e-01 | 0.185 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.560573e-01 | 0.183 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.560573e-01 | 0.183 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.560573e-01 | 0.183 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.560573e-01 | 0.183 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.560573e-01 | 0.183 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.560573e-01 | 0.183 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.560573e-01 | 0.183 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.560573e-01 | 0.183 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.560573e-01 | 0.183 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.560573e-01 | 0.183 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.560573e-01 | 0.183 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.603327e-01 | 0.180 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.675477e-01 | 0.176 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.675477e-01 | 0.176 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.679168e-01 | 0.175 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.680259e-01 | 0.175 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.693991e-01 | 0.174 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.693991e-01 | 0.174 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.693991e-01 | 0.174 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.693991e-01 | 0.174 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 6.693991e-01 | 0.174 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.693991e-01 | 0.174 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.693991e-01 | 0.174 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 6.693991e-01 | 0.174 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.693991e-01 | 0.174 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.753766e-01 | 0.170 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.759704e-01 | 0.170 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.766149e-01 | 0.170 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.766149e-01 | 0.170 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.778661e-01 | 0.169 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.822242e-01 | 0.166 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.822242e-01 | 0.166 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.822242e-01 | 0.166 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.822242e-01 | 0.166 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.822242e-01 | 0.166 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.822242e-01 | 0.166 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 6.822242e-01 | 0.166 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.822242e-01 | 0.166 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 6.822242e-01 | 0.166 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.822242e-01 | 0.166 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.822242e-01 | 0.166 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.827121e-01 | 0.166 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.836176e-01 | 0.165 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.854798e-01 | 0.164 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.854798e-01 | 0.164 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.854798e-01 | 0.164 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.854798e-01 | 0.164 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.854798e-01 | 0.164 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.857489e-01 | 0.164 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.910797e-01 | 0.160 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.941444e-01 | 0.159 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.941444e-01 | 0.159 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.941444e-01 | 0.159 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.941444e-01 | 0.159 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.941444e-01 | 0.159 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.941444e-01 | 0.159 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.945525e-01 | 0.158 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.945525e-01 | 0.158 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.945525e-01 | 0.158 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.945525e-01 | 0.158 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.970112e-01 | 0.157 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.974963e-01 | 0.156 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.009045e-01 | 0.154 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.024504e-01 | 0.153 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.026109e-01 | 0.153 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.026109e-01 | 0.153 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.034343e-01 | 0.153 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.035955e-01 | 0.153 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.064033e-01 | 0.151 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.064033e-01 | 0.151 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.064033e-01 | 0.151 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.064033e-01 | 0.151 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.064033e-01 | 0.151 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.064033e-01 | 0.151 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 7.064033e-01 | 0.151 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.064033e-01 | 0.151 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.064033e-01 | 0.151 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.064033e-01 | 0.151 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.108171e-01 | 0.148 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.108817e-01 | 0.148 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.108817e-01 | 0.148 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.177949e-01 | 0.144 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.177949e-01 | 0.144 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.177949e-01 | 0.144 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.177949e-01 | 0.144 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.177949e-01 | 0.144 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.177949e-01 | 0.144 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.177949e-01 | 0.144 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.177949e-01 | 0.144 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.189591e-01 | 0.143 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.189591e-01 | 0.143 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.189591e-01 | 0.143 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.213576e-01 | 0.142 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.229158e-01 | 0.141 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.268458e-01 | 0.139 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.271003e-01 | 0.138 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.287453e-01 | 0.137 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.287453e-01 | 0.137 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.287453e-01 | 0.137 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.287453e-01 | 0.137 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.287453e-01 | 0.137 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.287453e-01 | 0.137 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.287453e-01 | 0.137 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 7.287453e-01 | 0.137 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.287453e-01 | 0.137 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.287453e-01 | 0.137 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.287453e-01 | 0.137 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.306109e-01 | 0.136 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.327544e-01 | 0.135 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.345443e-01 | 0.134 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.345443e-01 | 0.134 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.353220e-01 | 0.134 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.392713e-01 | 0.131 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.392713e-01 | 0.131 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.392713e-01 | 0.131 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.392713e-01 | 0.131 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.392713e-01 | 0.131 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.392713e-01 | 0.131 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.392713e-01 | 0.131 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.392713e-01 | 0.131 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.392713e-01 | 0.131 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.392713e-01 | 0.131 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.392713e-01 | 0.131 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.420574e-01 | 0.130 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.458087e-01 | 0.127 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.471855e-01 | 0.127 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.491881e-01 | 0.125 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.493244e-01 | 0.125 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.493878e-01 | 0.125 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.493896e-01 | 0.125 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.493896e-01 | 0.125 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.493896e-01 | 0.125 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.493896e-01 | 0.125 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.493896e-01 | 0.125 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.493896e-01 | 0.125 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.493896e-01 | 0.125 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.493896e-01 | 0.125 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.493896e-01 | 0.125 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 7.493896e-01 | 0.125 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.493896e-01 | 0.125 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.565385e-01 | 0.121 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.565385e-01 | 0.121 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.591157e-01 | 0.120 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.591157e-01 | 0.120 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.591157e-01 | 0.120 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.591157e-01 | 0.120 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.591157e-01 | 0.120 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.606443e-01 | 0.119 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.635123e-01 | 0.117 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.635123e-01 | 0.117 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.635123e-01 | 0.117 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.635123e-01 | 0.117 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.648372e-01 | 0.116 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.669829e-01 | 0.115 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.684650e-01 | 0.114 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 7.684650e-01 | 0.114 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.684650e-01 | 0.114 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.684650e-01 | 0.114 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.684650e-01 | 0.114 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.703121e-01 | 0.113 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.703121e-01 | 0.113 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.703121e-01 | 0.113 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.769410e-01 | 0.110 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.769410e-01 | 0.110 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.774519e-01 | 0.109 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.774519e-01 | 0.109 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.774519e-01 | 0.109 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.781835e-01 | 0.109 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.781835e-01 | 0.109 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.834020e-01 | 0.106 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.836157e-01 | 0.106 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 7.860905e-01 | 0.105 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.860905e-01 | 0.105 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.860905e-01 | 0.105 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.860905e-01 | 0.105 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.860905e-01 | 0.105 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.860905e-01 | 0.105 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.922726e-01 | 0.101 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.943943e-01 | 0.100 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.943943e-01 | 0.100 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.943943e-01 | 0.100 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.943943e-01 | 0.100 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.943943e-01 | 0.100 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.958324e-01 | 0.099 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.958324e-01 | 0.099 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.018079e-01 | 0.096 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.023763e-01 | 0.096 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.023763e-01 | 0.096 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.023763e-01 | 0.096 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.023763e-01 | 0.096 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.023763e-01 | 0.096 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.023763e-01 | 0.096 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.023763e-01 | 0.096 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.023763e-01 | 0.096 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.023763e-01 | 0.096 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.076277e-01 | 0.093 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.087908e-01 | 0.092 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.100489e-01 | 0.091 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.100489e-01 | 0.091 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.100489e-01 | 0.091 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.100489e-01 | 0.091 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.100489e-01 | 0.091 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.174240e-01 | 0.088 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.174240e-01 | 0.088 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.174240e-01 | 0.088 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.179879e-01 | 0.087 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.188126e-01 | 0.087 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.188126e-01 | 0.087 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.188126e-01 | 0.087 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.203096e-01 | 0.086 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.232139e-01 | 0.084 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.245132e-01 | 0.084 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 8.245132e-01 | 0.084 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.245132e-01 | 0.084 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.245132e-01 | 0.084 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.245132e-01 | 0.084 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.245132e-01 | 0.084 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 8.245132e-01 | 0.084 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.245132e-01 | 0.084 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.245132e-01 | 0.084 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.259598e-01 | 0.083 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.294115e-01 | 0.081 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.313275e-01 | 0.080 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.313275e-01 | 0.080 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.313275e-01 | 0.080 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.313275e-01 | 0.080 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.363857e-01 | 0.078 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.378777e-01 | 0.077 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.378777e-01 | 0.077 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.378777e-01 | 0.077 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.378777e-01 | 0.077 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.378777e-01 | 0.077 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.378777e-01 | 0.077 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.394488e-01 | 0.076 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.441739e-01 | 0.074 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.441739e-01 | 0.074 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.441739e-01 | 0.074 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.487033e-01 | 0.071 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.502259e-01 | 0.070 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.502259e-01 | 0.070 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.502259e-01 | 0.070 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.502259e-01 | 0.070 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.522663e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.535041e-01 | 0.069 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.535041e-01 | 0.069 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.560432e-01 | 0.068 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.560432e-01 | 0.068 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.560432e-01 | 0.068 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.560432e-01 | 0.068 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.560432e-01 | 0.068 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.560432e-01 | 0.068 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.572596e-01 | 0.067 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.616349e-01 | 0.065 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.622415e-01 | 0.064 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.668548e-01 | 0.062 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.670098e-01 | 0.062 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.670098e-01 | 0.062 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.701255e-01 | 0.060 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.721761e-01 | 0.059 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.721761e-01 | 0.059 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.744555e-01 | 0.058 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 8.771421e-01 | 0.057 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.771421e-01 | 0.057 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.783000e-01 | 0.056 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 8.809360e-01 | 0.055 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.810344e-01 | 0.055 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.819154e-01 | 0.055 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.819154e-01 | 0.055 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.819154e-01 | 0.055 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.819154e-01 | 0.055 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.819154e-01 | 0.055 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.819154e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.819154e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.819154e-01 | 0.055 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.822035e-01 | 0.054 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.878778e-01 | 0.052 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.891910e-01 | 0.051 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.909138e-01 | 0.050 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.951528e-01 | 0.048 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.951528e-01 | 0.048 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 8.951528e-01 | 0.048 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.031439e-01 | 0.044 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.031439e-01 | 0.044 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.056568e-01 | 0.043 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.069083e-01 | 0.042 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.105267e-01 | 0.041 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.105267e-01 | 0.041 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.111806e-01 | 0.040 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.205609e-01 | 0.036 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.205609e-01 | 0.036 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.205609e-01 | 0.036 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.266179e-01 | 0.033 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.294713e-01 | 0.032 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.294713e-01 | 0.032 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.296694e-01 | 0.032 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.300021e-01 | 0.032 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.312851e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.322139e-01 | 0.030 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.322139e-01 | 0.030 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.322139e-01 | 0.030 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.322139e-01 | 0.030 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.322139e-01 | 0.030 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.322139e-01 | 0.030 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.322139e-01 | 0.030 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.334722e-01 | 0.030 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.339673e-01 | 0.030 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.348499e-01 | 0.029 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.348499e-01 | 0.029 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.355932e-01 | 0.029 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.373836e-01 | 0.028 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.373836e-01 | 0.028 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.379488e-01 | 0.028 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.379488e-01 | 0.028 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.407487e-01 | 0.027 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.421597e-01 | 0.026 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.428807e-01 | 0.026 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.452711e-01 | 0.024 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.465721e-01 | 0.024 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.470330e-01 | 0.024 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.472130e-01 | 0.024 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.472130e-01 | 0.024 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.472130e-01 | 0.024 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.486505e-01 | 0.023 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.503961e-01 | 0.022 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.506483e-01 | 0.022 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.506483e-01 | 0.022 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.522463e-01 | 0.021 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.535549e-01 | 0.021 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.561878e-01 | 0.019 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.595314e-01 | 0.018 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.617631e-01 | 0.017 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.626202e-01 | 0.017 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.626202e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.626202e-01 | 0.017 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.631640e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.639662e-01 | 0.016 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.640751e-01 | 0.016 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.655386e-01 | 0.015 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.655386e-01 | 0.015 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.670480e-01 | 0.015 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.681095e-01 | 0.014 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.683946e-01 | 0.014 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.689626e-01 | 0.014 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.705444e-01 | 0.013 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.705444e-01 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.727440e-01 | 0.012 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.745201e-01 | 0.011 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.745201e-01 | 0.011 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.745201e-01 | 0.011 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.758502e-01 | 0.011 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.790577e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.790577e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.802015e-01 | 0.009 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.805700e-01 | 0.009 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.810318e-01 | 0.008 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.810949e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.824268e-01 | 0.008 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.844023e-01 | 0.007 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.855945e-01 | 0.006 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.866958e-01 | 0.006 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.880953e-01 | 0.005 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.890949e-01 | 0.005 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.895202e-01 | 0.005 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.911947e-01 | 0.004 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.926747e-01 | 0.003 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.928561e-01 | 0.003 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.934993e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.939968e-01 | 0.003 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.959690e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.960833e-01 | 0.002 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.962070e-01 | 0.002 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.964562e-01 | 0.002 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.970809e-01 | 0.001 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.974458e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.976093e-01 | 0.001 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.977303e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.977338e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.977830e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.978697e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.982788e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.983231e-01 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.984517e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.987318e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.987460e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.988291e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.994733e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.995776e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.996018e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.996524e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.996868e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998414e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998489e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999624e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999705e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999902e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999931e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999939e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999942e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999987e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999990e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999995e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.332268e-15 | 14.875 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.256772e-13 | 12.901 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.604583e-13 | 12.584 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.406164e-13 | 12.468 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.069944e-11 | 10.971 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.000000e-11 | 11.000 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.000000e-11 | 11.000 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.004585e-11 | 10.998 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.275036e-11 | 10.894 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.717049e-11 | 10.566 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.831491e-11 | 10.417 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.085110e-11 | 10.389 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.081990e-11 | 10.389 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.257372e-11 | 10.204 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.198829e-10 | 9.921 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.198829e-10 | 9.921 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.699252e-10 | 9.770 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.984284e-10 | 9.702 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.995774e-10 | 9.523 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.159630e-10 | 9.381 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.116749e-10 | 9.385 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.540450e-10 | 9.256 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.152317e-09 | 8.938 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.720972e-09 | 8.565 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.984298e-09 | 8.525 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.042426e-09 | 8.393 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.693362e-09 | 8.329 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.236626e-08 | 7.908 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.550943e-08 | 7.809 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.273233e-08 | 7.369 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.979943e-08 | 7.223 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.454781e-08 | 7.073 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.335762e-07 | 6.874 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.453076e-07 | 6.838 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.684396e-07 | 6.774 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.717015e-07 | 6.765 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.195685e-07 | 6.658 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.386769e-07 | 6.622 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.504450e-07 | 6.601 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.789701e-07 | 6.554 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.813376e-07 | 6.551 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.962932e-07 | 6.528 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.998823e-07 | 6.523 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.214772e-07 | 6.493 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.342502e-07 | 6.476 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.671473e-07 | 6.435 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.234700e-07 | 6.373 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.234700e-07 | 6.373 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.542220e-07 | 6.343 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.726086e-07 | 6.325 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.975449e-07 | 6.224 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.954192e-07 | 6.158 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.963259e-07 | 6.048 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.722698e-07 | 6.012 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.097063e-06 | 5.960 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.171533e-06 | 5.931 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.243606e-06 | 5.905 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.764336e-06 | 5.753 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.875150e-06 | 5.727 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.938435e-06 | 5.713 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.953705e-06 | 5.709 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.171405e-06 | 5.663 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.919595e-06 | 5.535 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.179080e-06 | 5.498 | 0 | 0 |
| Translation | R-HSA-72766 | 3.689740e-06 | 5.433 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.444489e-06 | 5.352 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.415545e-06 | 5.355 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.472237e-06 | 5.349 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.594431e-06 | 5.338 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.797300e-06 | 5.319 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.162447e-06 | 5.287 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.485996e-06 | 5.261 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.645115e-06 | 5.248 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.150020e-06 | 5.146 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.852002e-06 | 5.105 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.003197e-06 | 5.097 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.140471e-05 | 4.943 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.159636e-05 | 4.936 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.313791e-05 | 4.881 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.361150e-05 | 4.866 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.545685e-05 | 4.811 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.574488e-05 | 4.803 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.723910e-05 | 4.763 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.081899e-05 | 4.682 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.304429e-05 | 4.637 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.327807e-05 | 4.633 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.700346e-05 | 4.569 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.047238e-05 | 4.516 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.976530e-05 | 4.400 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.291131e-05 | 4.367 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.528349e-05 | 4.344 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.086662e-05 | 4.294 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.126574e-05 | 4.290 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.573119e-05 | 4.254 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.661178e-05 | 4.176 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.889515e-05 | 4.103 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.246298e-05 | 4.084 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.484711e-05 | 4.071 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.216387e-05 | 4.035 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.630635e-05 | 4.016 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.144461e-04 | 3.941 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.265257e-04 | 3.898 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.445186e-04 | 3.840 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.445186e-04 | 3.840 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.528923e-04 | 3.816 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.539782e-04 | 3.813 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.945728e-04 | 3.711 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.540528e-04 | 3.595 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.540528e-04 | 3.595 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.845942e-04 | 3.546 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.874353e-04 | 3.541 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.485534e-04 | 3.458 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.673710e-04 | 3.435 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.703361e-04 | 3.431 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.726713e-04 | 3.429 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.726713e-04 | 3.429 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.980020e-04 | 3.400 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.869485e-04 | 3.313 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.869485e-04 | 3.313 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.456483e-04 | 3.263 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.033181e-04 | 3.298 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.228264e-04 | 3.282 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.631092e-04 | 3.249 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.920781e-04 | 3.228 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.097265e-04 | 3.215 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.255312e-04 | 3.204 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.850758e-04 | 3.233 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.911725e-04 | 3.228 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.321629e-04 | 3.199 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.250365e-04 | 3.204 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.037541e-04 | 3.095 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.187377e-04 | 3.087 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.187377e-04 | 3.087 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.720310e-04 | 3.112 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.037541e-04 | 3.095 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.037541e-04 | 3.095 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.565490e-04 | 3.121 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.862069e-04 | 3.104 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.406372e-04 | 3.130 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.268916e-04 | 3.083 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.320150e-04 | 3.080 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.320150e-04 | 3.080 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.320150e-04 | 3.080 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.320150e-04 | 3.080 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 8.320150e-04 | 3.080 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.002682e-04 | 3.046 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.870187e-04 | 3.006 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.870187e-04 | 3.006 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.883442e-04 | 3.005 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.144590e-03 | 2.941 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.069385e-03 | 2.971 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.144590e-03 | 2.941 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.121256e-03 | 2.950 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.128991e-03 | 2.947 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.007874e-03 | 2.997 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.268656e-03 | 2.897 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.295813e-03 | 2.887 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.300939e-03 | 2.886 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.406088e-03 | 2.852 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.430102e-03 | 2.845 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.531367e-03 | 2.815 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.531367e-03 | 2.815 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.531367e-03 | 2.815 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.531367e-03 | 2.815 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.732082e-03 | 2.761 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.852145e-03 | 2.732 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.902057e-03 | 2.721 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.908361e-03 | 2.719 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.988099e-03 | 2.702 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.988099e-03 | 2.702 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.000854e-03 | 2.699 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.000854e-03 | 2.699 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.223534e-03 | 2.653 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.223534e-03 | 2.653 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.388842e-03 | 2.622 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.194786e-03 | 2.659 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.127276e-03 | 2.672 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.194786e-03 | 2.659 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.334590e-03 | 2.632 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.520249e-03 | 2.599 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.561428e-03 | 2.592 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.561428e-03 | 2.592 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.561428e-03 | 2.592 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.601595e-03 | 2.585 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.646382e-03 | 2.577 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.124619e-03 | 2.505 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.880671e-03 | 2.541 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.078363e-03 | 2.512 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.151695e-03 | 2.501 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.151695e-03 | 2.501 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.711346e-03 | 2.567 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.124619e-03 | 2.505 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.221275e-03 | 2.492 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.743240e-03 | 2.562 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.880671e-03 | 2.541 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 3.221275e-03 | 2.492 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 3.221275e-03 | 2.492 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.801308e-03 | 2.553 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.221275e-03 | 2.492 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.221275e-03 | 2.492 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.986247e-03 | 2.525 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.324746e-03 | 2.478 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.376275e-03 | 2.472 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.420584e-03 | 2.466 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.471135e-03 | 2.460 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.476876e-03 | 2.459 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.582595e-03 | 2.446 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.647196e-03 | 2.438 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.662182e-03 | 2.436 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.662182e-03 | 2.436 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.662182e-03 | 2.436 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.691739e-03 | 2.433 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.691739e-03 | 2.433 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.715456e-03 | 2.430 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.834526e-03 | 2.316 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.717495e-03 | 2.326 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.517219e-03 | 2.345 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.399930e-03 | 2.357 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.870233e-03 | 2.312 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.988329e-03 | 2.399 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.263000e-03 | 2.370 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.870233e-03 | 2.312 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.434379e-03 | 2.353 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.870233e-03 | 2.312 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.717495e-03 | 2.326 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.797364e-03 | 2.319 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.405550e-03 | 2.356 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.901260e-03 | 2.409 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.263000e-03 | 2.370 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.920297e-03 | 2.407 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.978753e-03 | 2.303 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.978753e-03 | 2.303 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.215344e-03 | 2.283 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.287034e-03 | 2.277 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.287034e-03 | 2.277 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.287034e-03 | 2.277 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.299884e-03 | 2.276 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.354246e-03 | 2.271 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.474872e-03 | 2.262 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.533969e-03 | 2.257 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.592157e-03 | 2.252 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.660592e-03 | 2.247 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.660592e-03 | 2.247 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.669950e-03 | 2.246 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.755376e-03 | 2.240 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.874292e-03 | 2.231 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.874292e-03 | 2.231 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.874292e-03 | 2.231 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.874292e-03 | 2.231 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.874292e-03 | 2.231 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.874292e-03 | 2.231 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.905355e-03 | 2.229 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.905355e-03 | 2.229 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.953478e-03 | 2.225 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.007127e-03 | 2.221 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.007127e-03 | 2.221 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.136402e-03 | 2.212 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.574778e-03 | 2.182 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.574778e-03 | 2.182 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.776991e-03 | 2.169 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.007444e-03 | 2.154 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.007444e-03 | 2.154 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.007444e-03 | 2.154 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.010834e-03 | 2.154 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.171083e-03 | 2.144 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.276232e-03 | 2.082 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.528717e-03 | 2.069 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.760885e-03 | 2.110 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.575179e-03 | 2.121 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.634877e-03 | 2.016 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.836312e-03 | 2.106 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.809392e-03 | 2.008 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.907057e-03 | 2.050 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.809392e-03 | 2.008 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.686778e-03 | 2.014 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.821016e-03 | 2.107 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.276232e-03 | 2.082 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.528717e-03 | 2.069 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.076154e-03 | 2.093 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.821016e-03 | 2.107 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.634877e-03 | 2.016 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.051118e-03 | 2.094 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.376056e-03 | 2.132 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.076154e-03 | 2.093 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.276232e-03 | 2.082 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.836312e-03 | 2.106 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.276232e-03 | 2.082 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.686778e-03 | 2.014 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.985048e-03 | 2.001 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.985048e-03 | 2.001 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.985048e-03 | 2.001 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.985048e-03 | 2.001 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.056012e-02 | 1.976 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.056012e-02 | 1.976 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.056012e-02 | 1.976 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.057516e-02 | 1.976 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.076853e-02 | 1.968 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.076853e-02 | 1.968 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.087569e-02 | 1.964 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.109914e-02 | 1.955 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.124477e-02 | 1.949 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.179225e-02 | 1.928 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.185968e-02 | 1.926 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.185968e-02 | 1.926 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.268041e-02 | 1.897 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.288267e-02 | 1.890 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.288267e-02 | 1.890 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.295545e-02 | 1.888 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.307080e-02 | 1.884 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.313940e-02 | 1.881 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.313940e-02 | 1.881 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.353923e-02 | 1.868 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.404186e-02 | 1.853 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.444124e-02 | 1.840 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.457556e-02 | 1.836 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.457556e-02 | 1.836 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.469114e-02 | 1.833 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.482359e-02 | 1.829 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.527182e-02 | 1.816 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.527182e-02 | 1.816 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.527182e-02 | 1.816 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.527182e-02 | 1.816 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.537673e-02 | 1.813 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.611330e-02 | 1.793 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.626538e-02 | 1.789 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.632248e-02 | 1.787 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.657452e-02 | 1.781 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.657452e-02 | 1.781 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.657452e-02 | 1.781 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.657452e-02 | 1.781 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.657452e-02 | 1.781 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.657452e-02 | 1.781 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.685352e-02 | 1.773 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.685352e-02 | 1.773 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.685352e-02 | 1.773 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.775538e-02 | 1.751 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.775538e-02 | 1.751 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.775538e-02 | 1.751 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.795184e-02 | 1.746 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.827325e-02 | 1.738 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.827325e-02 | 1.738 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.848922e-02 | 1.733 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.940561e-02 | 1.712 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.950438e-02 | 1.710 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.950438e-02 | 1.710 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.950438e-02 | 1.710 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.843303e-02 | 1.546 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.247568e-02 | 1.648 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.624465e-02 | 1.581 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.033031e-02 | 1.518 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.666106e-02 | 1.574 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.136272e-02 | 1.670 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.601900e-02 | 1.585 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.601900e-02 | 1.585 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.787971e-02 | 1.555 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.732220e-02 | 1.563 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.601900e-02 | 1.585 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.992362e-02 | 1.524 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.992362e-02 | 1.524 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.329079e-02 | 1.633 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.136272e-02 | 1.670 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.136272e-02 | 1.670 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.541624e-02 | 1.595 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.101550e-02 | 1.677 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.249498e-02 | 1.648 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.541624e-02 | 1.595 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.541624e-02 | 1.595 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.333264e-02 | 1.632 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.541624e-02 | 1.595 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.541624e-02 | 1.595 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.982619e-02 | 1.525 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.787971e-02 | 1.555 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.341921e-02 | 1.630 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.856677e-02 | 1.544 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.993184e-02 | 1.524 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.004684e-02 | 1.522 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.033031e-02 | 1.518 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.993184e-02 | 1.524 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.761540e-02 | 1.559 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.141365e-02 | 1.669 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.093757e-02 | 1.679 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.093757e-02 | 1.679 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.424271e-02 | 1.615 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.666106e-02 | 1.574 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.666106e-02 | 1.574 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.635961e-02 | 1.579 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.993184e-02 | 1.524 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.784750e-02 | 1.555 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.433924e-02 | 1.614 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.170183e-02 | 1.499 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.185969e-02 | 1.497 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.185969e-02 | 1.497 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.191071e-02 | 1.496 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.236712e-02 | 1.490 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.236712e-02 | 1.490 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.236712e-02 | 1.490 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.236712e-02 | 1.490 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.261368e-02 | 1.487 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.261368e-02 | 1.487 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.261368e-02 | 1.487 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.368959e-02 | 1.473 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.398139e-02 | 1.469 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.398139e-02 | 1.469 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.473038e-02 | 1.459 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.492257e-02 | 1.457 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.492257e-02 | 1.457 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.492257e-02 | 1.457 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.492257e-02 | 1.457 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.543904e-02 | 1.451 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.585810e-02 | 1.445 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.585810e-02 | 1.445 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.585810e-02 | 1.445 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.585810e-02 | 1.445 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.605402e-02 | 1.443 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.625266e-02 | 1.441 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.625266e-02 | 1.441 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 3.645597e-02 | 1.438 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.759939e-02 | 1.425 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.759939e-02 | 1.425 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.759939e-02 | 1.425 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.759939e-02 | 1.425 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.759939e-02 | 1.425 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.759939e-02 | 1.425 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.928235e-02 | 1.406 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.934633e-02 | 1.405 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.039856e-02 | 1.394 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 4.088594e-02 | 1.388 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.106663e-02 | 1.387 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.288674e-02 | 1.368 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.288674e-02 | 1.368 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.378283e-02 | 1.359 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.479315e-02 | 1.349 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.480357e-02 | 1.349 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.594717e-02 | 1.338 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.636702e-02 | 1.334 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.667120e-02 | 1.331 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.820132e-02 | 1.317 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.839196e-02 | 1.315 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.845374e-02 | 1.315 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.861734e-02 | 1.313 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.908530e-02 | 1.309 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.953739e-02 | 1.305 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.953739e-02 | 1.305 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.063525e-02 | 1.296 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.063525e-02 | 1.296 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.063525e-02 | 1.296 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.080786e-02 | 1.294 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.138125e-02 | 1.289 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.138125e-02 | 1.289 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.138125e-02 | 1.289 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.283228e-02 | 1.277 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.283228e-02 | 1.277 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.341399e-02 | 1.272 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.341399e-02 | 1.272 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.341399e-02 | 1.272 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.341399e-02 | 1.272 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.399174e-02 | 1.268 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.399174e-02 | 1.268 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.399174e-02 | 1.268 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.399174e-02 | 1.268 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.453742e-02 | 1.263 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.539046e-02 | 1.257 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.782273e-02 | 1.238 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.909849e-02 | 1.228 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.909849e-02 | 1.228 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.909849e-02 | 1.228 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.979586e-02 | 1.223 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.122353e-02 | 1.213 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.129115e-02 | 1.213 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.346423e-02 | 1.197 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.346423e-02 | 1.197 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.359499e-02 | 1.197 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.359499e-02 | 1.197 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.378927e-02 | 1.195 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.378927e-02 | 1.195 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.725651e-02 | 1.172 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.747171e-02 | 1.171 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.747171e-02 | 1.171 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.747171e-02 | 1.171 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.747171e-02 | 1.171 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.826576e-02 | 1.166 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.826576e-02 | 1.166 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.826576e-02 | 1.166 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.826576e-02 | 1.166 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.826576e-02 | 1.166 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.904272e-02 | 1.161 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.946071e-02 | 1.158 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.117214e-02 | 1.148 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.117214e-02 | 1.148 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 7.158504e-02 | 1.145 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 7.158504e-02 | 1.145 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.054354e-01 | 0.977 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.380536e-01 | 0.860 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.412999e-02 | 1.130 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.496144e-02 | 1.071 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.496144e-02 | 1.071 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.079019e-01 | 0.967 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.199208e-01 | 0.921 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.199208e-01 | 0.921 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.199208e-01 | 0.921 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.199208e-01 | 0.921 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.199208e-01 | 0.921 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.322499e-01 | 0.879 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.481991e-02 | 1.023 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.481991e-02 | 1.023 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.099376e-01 | 0.959 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.259108e-01 | 0.900 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.259108e-01 | 0.900 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.341922e-01 | 0.872 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.341922e-01 | 0.872 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.341922e-01 | 0.872 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.341922e-01 | 0.872 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.414953e-02 | 1.026 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.981189e-02 | 1.001 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.937039e-02 | 1.100 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.435388e-01 | 0.843 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.117964e-01 | 0.952 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.191285e-02 | 1.037 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.426561e-01 | 0.846 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.689594e-02 | 1.114 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.496144e-02 | 1.071 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.099376e-01 | 0.959 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.099376e-01 | 0.959 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.392385e-02 | 1.131 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.322499e-01 | 0.879 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.368829e-01 | 0.864 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.368829e-01 | 0.864 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 9.623423e-02 | 1.017 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.079019e-01 | 0.967 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.322499e-01 | 0.879 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.812128e-02 | 1.107 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.322499e-01 | 0.879 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.380536e-01 | 0.860 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.412999e-02 | 1.130 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.079019e-01 | 0.967 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.199208e-01 | 0.921 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.330095e-02 | 1.079 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.259108e-01 | 0.900 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.368829e-01 | 0.864 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.256998e-02 | 1.034 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.341922e-01 | 0.872 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.310938e-02 | 1.136 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.368829e-01 | 0.864 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.051039e-02 | 1.094 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.405875e-01 | 0.852 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.259441e-01 | 0.900 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.322499e-01 | 0.879 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.273757e-01 | 0.895 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.216868e-01 | 0.915 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.097014e-02 | 1.092 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.079019e-01 | 0.967 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.054354e-01 | 0.977 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.226724e-02 | 1.085 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.833999e-02 | 1.054 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.833999e-02 | 1.054 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.524580e-02 | 1.021 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.363571e-02 | 1.133 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.256998e-02 | 1.034 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.392385e-02 | 1.131 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.981189e-02 | 1.001 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 9.623423e-02 | 1.017 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.220762e-01 | 0.913 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.527183e-02 | 1.069 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.262149e-01 | 0.899 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.368829e-01 | 0.864 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.262149e-01 | 0.899 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.378154e-01 | 0.861 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.496144e-02 | 1.071 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.079019e-01 | 0.967 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.414953e-02 | 1.026 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.981189e-02 | 1.001 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.056283e-01 | 0.976 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.378154e-01 | 0.861 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.792416e-02 | 1.009 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.650925e-02 | 1.015 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.080727e-01 | 0.966 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.168823e-01 | 0.932 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.179967e-01 | 0.928 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.110879e-01 | 0.954 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.097014e-02 | 1.092 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.310815e-01 | 0.882 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.199208e-01 | 0.921 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.348532e-01 | 0.870 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.653907e-02 | 1.063 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.412999e-02 | 1.130 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.262149e-01 | 0.899 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.364562e-01 | 0.865 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.920824e-02 | 1.050 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.589803e-02 | 1.018 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.303561e-01 | 0.885 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.412999e-02 | 1.130 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.412999e-02 | 1.130 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.079019e-01 | 0.967 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.481991e-02 | 1.023 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.864476e-02 | 1.052 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.337548e-02 | 1.134 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.337548e-02 | 1.134 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.382832e-01 | 0.859 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.327789e-01 | 0.877 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.689594e-02 | 1.114 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.368829e-01 | 0.864 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.041404e-01 | 0.982 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.041404e-01 | 0.982 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.028398e-01 | 0.988 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.051039e-02 | 1.094 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.273757e-01 | 0.895 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.227235e-01 | 0.911 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.063879e-02 | 1.093 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.481991e-02 | 1.023 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.322499e-01 | 0.879 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.241165e-01 | 0.906 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.322499e-01 | 0.879 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.338903e-01 | 0.873 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.012447e-01 | 0.995 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.981189e-02 | 1.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.311294e-01 | 0.882 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.414953e-02 | 1.026 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.448508e-01 | 0.839 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.448703e-01 | 0.839 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.455143e-01 | 0.837 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.455757e-01 | 0.837 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.495861e-01 | 0.825 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.503194e-01 | 0.823 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.553796e-01 | 0.809 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.562264e-01 | 0.806 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.572198e-01 | 0.803 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.572198e-01 | 0.803 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.576873e-01 | 0.802 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.576873e-01 | 0.802 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.576873e-01 | 0.802 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.576873e-01 | 0.802 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.580039e-01 | 0.801 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.607548e-01 | 0.794 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.631219e-01 | 0.787 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.656088e-01 | 0.781 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.659829e-01 | 0.780 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.667847e-01 | 0.778 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.672378e-01 | 0.777 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.690379e-01 | 0.772 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.694844e-01 | 0.771 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.707256e-01 | 0.768 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.732971e-01 | 0.761 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.752703e-01 | 0.756 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.766506e-01 | 0.753 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.773493e-01 | 0.751 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.778674e-01 | 0.750 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.781270e-01 | 0.749 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.781270e-01 | 0.749 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.794396e-01 | 0.746 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.839339e-01 | 0.735 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.839339e-01 | 0.735 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.856623e-01 | 0.731 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.856623e-01 | 0.731 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.873465e-01 | 0.727 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 1.899384e-01 | 0.721 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.919626e-01 | 0.717 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.919626e-01 | 0.717 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.933536e-01 | 0.714 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.961933e-01 | 0.707 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.966864e-01 | 0.706 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.972827e-01 | 0.705 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.972827e-01 | 0.705 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.972827e-01 | 0.705 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.972827e-01 | 0.705 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 1.972827e-01 | 0.705 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 1.983374e-01 | 0.703 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.993910e-01 | 0.700 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.997708e-01 | 0.699 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.997708e-01 | 0.699 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.997796e-01 | 0.699 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.058469e-01 | 0.686 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.084773e-01 | 0.681 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.094125e-01 | 0.679 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.107441e-01 | 0.676 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.107441e-01 | 0.676 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.107441e-01 | 0.676 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.107441e-01 | 0.676 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 2.111699e-01 | 0.675 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.112990e-01 | 0.675 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.126782e-01 | 0.672 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.156871e-01 | 0.666 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.156871e-01 | 0.666 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.156871e-01 | 0.666 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.161630e-01 | 0.665 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.242924e-01 | 0.649 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.242924e-01 | 0.649 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.242924e-01 | 0.649 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.242924e-01 | 0.649 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.242924e-01 | 0.649 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.277826e-01 | 0.642 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.289546e-01 | 0.640 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.289546e-01 | 0.640 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.289546e-01 | 0.640 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.289546e-01 | 0.640 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.289546e-01 | 0.640 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.289546e-01 | 0.640 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.337409e-01 | 0.631 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.379032e-01 | 0.624 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.379032e-01 | 0.624 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.379032e-01 | 0.624 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.379870e-01 | 0.623 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.396566e-01 | 0.620 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.396566e-01 | 0.620 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.396566e-01 | 0.620 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.397473e-01 | 0.620 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.448008e-01 | 0.611 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.448464e-01 | 0.611 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.448464e-01 | 0.611 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.476170e-01 | 0.606 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.476170e-01 | 0.606 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 2.476170e-01 | 0.606 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.476170e-01 | 0.606 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.476170e-01 | 0.606 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.476170e-01 | 0.606 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.476170e-01 | 0.606 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.476170e-01 | 0.606 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.483825e-01 | 0.605 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.515542e-01 | 0.599 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.515542e-01 | 0.599 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.516653e-01 | 0.599 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.547045e-01 | 0.594 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.547045e-01 | 0.594 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.547045e-01 | 0.594 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.547045e-01 | 0.594 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.558272e-01 | 0.592 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.570758e-01 | 0.590 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.570758e-01 | 0.590 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.570758e-01 | 0.590 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.570758e-01 | 0.590 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.646170e-01 | 0.577 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.646170e-01 | 0.577 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.652242e-01 | 0.576 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.652242e-01 | 0.576 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.652242e-01 | 0.576 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.652242e-01 | 0.576 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.652242e-01 | 0.576 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.783569e-01 | 0.555 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.788939e-01 | 0.555 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.788939e-01 | 0.555 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.788939e-01 | 0.555 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.788939e-01 | 0.555 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.788939e-01 | 0.555 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.795701e-01 | 0.554 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.841731e-01 | 0.546 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.841731e-01 | 0.546 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.841731e-01 | 0.546 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.841731e-01 | 0.546 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 2.841731e-01 | 0.546 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.841731e-01 | 0.546 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.845711e-01 | 0.546 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.892781e-01 | 0.539 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.892781e-01 | 0.539 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.922858e-01 | 0.534 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.925450e-01 | 0.534 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.937487e-01 | 0.532 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.945963e-01 | 0.531 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.964009e-01 | 0.528 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.970108e-01 | 0.527 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.046430e-01 | 0.516 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.061609e-01 | 0.514 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.061609e-01 | 0.514 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.061609e-01 | 0.514 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.061609e-01 | 0.514 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.093819e-01 | 0.510 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.102836e-01 | 0.508 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.102836e-01 | 0.508 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.102836e-01 | 0.508 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.129405e-01 | 0.505 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.129869e-01 | 0.504 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.189594e-01 | 0.496 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.197260e-01 | 0.495 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.197260e-01 | 0.495 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.197260e-01 | 0.495 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.197260e-01 | 0.495 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.212425e-01 | 0.493 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.268253e-01 | 0.486 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.296669e-01 | 0.482 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.296669e-01 | 0.482 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.332258e-01 | 0.477 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.332258e-01 | 0.477 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.354432e-01 | 0.474 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.354432e-01 | 0.474 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.354432e-01 | 0.474 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.354432e-01 | 0.474 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.354432e-01 | 0.474 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.377978e-01 | 0.471 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.466471e-01 | 0.460 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.466471e-01 | 0.460 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 3.545669e-01 | 0.450 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.596865e-01 | 0.444 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.596865e-01 | 0.444 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.596865e-01 | 0.444 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.596865e-01 | 0.444 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.596865e-01 | 0.444 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.596865e-01 | 0.444 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.596865e-01 | 0.444 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.649710e-01 | 0.438 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.659769e-01 | 0.437 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.719237e-01 | 0.430 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.732066e-01 | 0.428 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.732066e-01 | 0.428 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.791698e-01 | 0.421 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.830468e-01 | 0.417 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.830468e-01 | 0.417 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.830468e-01 | 0.417 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.830468e-01 | 0.417 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.830468e-01 | 0.417 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.830468e-01 | 0.417 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.849398e-01 | 0.415 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.849398e-01 | 0.415 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.863231e-01 | 0.413 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.863231e-01 | 0.413 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.863231e-01 | 0.413 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.863909e-01 | 0.413 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.948709e-01 | 0.404 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.948709e-01 | 0.404 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.993181e-01 | 0.399 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.023153e-01 | 0.395 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.044744e-01 | 0.393 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.055563e-01 | 0.392 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.055563e-01 | 0.392 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.055563e-01 | 0.392 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 4.055563e-01 | 0.392 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.055563e-01 | 0.392 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.055563e-01 | 0.392 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 4.055563e-01 | 0.392 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.055563e-01 | 0.392 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.055563e-01 | 0.392 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.055563e-01 | 0.392 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.062722e-01 | 0.391 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.096519e-01 | 0.388 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.121830e-01 | 0.385 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.121830e-01 | 0.385 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.121830e-01 | 0.385 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.127367e-01 | 0.384 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.207784e-01 | 0.376 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.243887e-01 | 0.372 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.249099e-01 | 0.372 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.249099e-01 | 0.372 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.262265e-01 | 0.370 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.272458e-01 | 0.369 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.272458e-01 | 0.369 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.272458e-01 | 0.369 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.272458e-01 | 0.369 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.272458e-01 | 0.369 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.272458e-01 | 0.369 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.272458e-01 | 0.369 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.272458e-01 | 0.369 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.272458e-01 | 0.369 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.272458e-01 | 0.369 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.311979e-01 | 0.365 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 4.312776e-01 | 0.365 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.321999e-01 | 0.364 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.341200e-01 | 0.362 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.374918e-01 | 0.359 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.437899e-01 | 0.353 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.437899e-01 | 0.353 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 4.437899e-01 | 0.353 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.441207e-01 | 0.352 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.481452e-01 | 0.349 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.481452e-01 | 0.349 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.481452e-01 | 0.349 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.481452e-01 | 0.349 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.481452e-01 | 0.349 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 4.481452e-01 | 0.349 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.481452e-01 | 0.349 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.481452e-01 | 0.349 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.481452e-01 | 0.349 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 4.481452e-01 | 0.349 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.481452e-01 | 0.349 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.481452e-01 | 0.349 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.499224e-01 | 0.347 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.499224e-01 | 0.347 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.534725e-01 | 0.343 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.559987e-01 | 0.341 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.621960e-01 | 0.335 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.621960e-01 | 0.335 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.682833e-01 | 0.329 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.682833e-01 | 0.329 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.682833e-01 | 0.329 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.682833e-01 | 0.329 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.682833e-01 | 0.329 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.682833e-01 | 0.329 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.682833e-01 | 0.329 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.697141e-01 | 0.328 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.723913e-01 | 0.326 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.743074e-01 | 0.324 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.743074e-01 | 0.324 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.743074e-01 | 0.324 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 4.743074e-01 | 0.324 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 4.793317e-01 | 0.319 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.795881e-01 | 0.319 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.876876e-01 | 0.312 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.876876e-01 | 0.312 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.876876e-01 | 0.312 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.876876e-01 | 0.312 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.876876e-01 | 0.312 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 4.876876e-01 | 0.312 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.876876e-01 | 0.312 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.912812e-01 | 0.309 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.980265e-01 | 0.303 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.980265e-01 | 0.303 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.980265e-01 | 0.303 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.013594e-01 | 0.300 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.063850e-01 | 0.296 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.063850e-01 | 0.296 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.063850e-01 | 0.296 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.063850e-01 | 0.296 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.063850e-01 | 0.296 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.063850e-01 | 0.296 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.063850e-01 | 0.296 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.096268e-01 | 0.293 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.210500e-01 | 0.283 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.210500e-01 | 0.283 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.210500e-01 | 0.283 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.210500e-01 | 0.283 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.244011e-01 | 0.280 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.244011e-01 | 0.280 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.244011e-01 | 0.280 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 5.244011e-01 | 0.280 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.244011e-01 | 0.280 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.244011e-01 | 0.280 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.244011e-01 | 0.280 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.244011e-01 | 0.280 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.244011e-01 | 0.280 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.244011e-01 | 0.280 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.273702e-01 | 0.278 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.273702e-01 | 0.278 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.273702e-01 | 0.278 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.274486e-01 | 0.278 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.284326e-01 | 0.277 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.322937e-01 | 0.274 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.322937e-01 | 0.274 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.335081e-01 | 0.273 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.363132e-01 | 0.271 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.373478e-01 | 0.270 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.417607e-01 | 0.266 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.417607e-01 | 0.266 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.417607e-01 | 0.266 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.417607e-01 | 0.266 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.417607e-01 | 0.266 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.417607e-01 | 0.266 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 5.417607e-01 | 0.266 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.417607e-01 | 0.266 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 5.417607e-01 | 0.266 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.417607e-01 | 0.266 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.419587e-01 | 0.266 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.433558e-01 | 0.265 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.433558e-01 | 0.265 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.433558e-01 | 0.265 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.433558e-01 | 0.265 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.537547e-01 | 0.257 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.539647e-01 | 0.257 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.542345e-01 | 0.256 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.577137e-01 | 0.254 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.584876e-01 | 0.253 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.584876e-01 | 0.253 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 5.584876e-01 | 0.253 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.584876e-01 | 0.253 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.584876e-01 | 0.253 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.584876e-01 | 0.253 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.584876e-01 | 0.253 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.584876e-01 | 0.253 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.642048e-01 | 0.249 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.649284e-01 | 0.248 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.746050e-01 | 0.241 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 5.746050e-01 | 0.241 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.746050e-01 | 0.241 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.746050e-01 | 0.241 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.746050e-01 | 0.241 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.754367e-01 | 0.240 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.817394e-01 | 0.235 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.836592e-01 | 0.234 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.836592e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.857585e-01 | 0.232 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.857585e-01 | 0.232 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.874370e-01 | 0.231 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.874370e-01 | 0.231 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.901350e-01 | 0.229 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.901350e-01 | 0.229 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.901350e-01 | 0.229 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 5.901350e-01 | 0.229 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 5.901350e-01 | 0.229 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.901350e-01 | 0.229 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.901350e-01 | 0.229 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.901350e-01 | 0.229 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.901350e-01 | 0.229 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 5.901350e-01 | 0.229 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.958936e-01 | 0.225 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.036551e-01 | 0.219 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.042725e-01 | 0.219 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.050989e-01 | 0.218 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.050989e-01 | 0.218 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.050989e-01 | 0.218 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.050989e-01 | 0.218 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.050989e-01 | 0.218 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.050989e-01 | 0.218 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.116046e-01 | 0.214 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.131499e-01 | 0.212 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.183687e-01 | 0.209 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.194466e-01 | 0.208 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.194466e-01 | 0.208 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.195173e-01 | 0.208 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.195173e-01 | 0.208 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.195173e-01 | 0.208 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.195173e-01 | 0.208 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.195173e-01 | 0.208 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.216608e-01 | 0.206 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.250895e-01 | 0.204 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.250895e-01 | 0.204 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.312059e-01 | 0.200 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.334102e-01 | 0.198 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.334102e-01 | 0.198 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.334102e-01 | 0.198 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.334102e-01 | 0.198 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.334102e-01 | 0.198 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.344116e-01 | 0.198 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 6.437710e-01 | 0.191 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.467966e-01 | 0.189 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.467966e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.467966e-01 | 0.189 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.467966e-01 | 0.189 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.467966e-01 | 0.189 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.527910e-01 | 0.185 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.532667e-01 | 0.185 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 6.596950e-01 | 0.181 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.596950e-01 | 0.181 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.596950e-01 | 0.181 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.596950e-01 | 0.181 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 6.641643e-01 | 0.178 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.712874e-01 | 0.173 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.721231e-01 | 0.173 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.721231e-01 | 0.173 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.721231e-01 | 0.173 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.721231e-01 | 0.173 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.760948e-01 | 0.170 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.782541e-01 | 0.169 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.840981e-01 | 0.165 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.840981e-01 | 0.165 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.840981e-01 | 0.165 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.840981e-01 | 0.165 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 6.840981e-01 | 0.165 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.840981e-01 | 0.165 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 6.893055e-01 | 0.162 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 6.951766e-01 | 0.158 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 6.956364e-01 | 0.158 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.956364e-01 | 0.158 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.956364e-01 | 0.158 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.956364e-01 | 0.158 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 6.956364e-01 | 0.158 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.067540e-01 | 0.151 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.067540e-01 | 0.151 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.067540e-01 | 0.151 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.067540e-01 | 0.151 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.067540e-01 | 0.151 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.067540e-01 | 0.151 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.067540e-01 | 0.151 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.108944e-01 | 0.148 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.166086e-01 | 0.145 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.174661e-01 | 0.144 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.174661e-01 | 0.144 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.174661e-01 | 0.144 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.174661e-01 | 0.144 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.174661e-01 | 0.144 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.259284e-01 | 0.139 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.259284e-01 | 0.139 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.277875e-01 | 0.138 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.277875e-01 | 0.138 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.277875e-01 | 0.138 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.277875e-01 | 0.138 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.331943e-01 | 0.135 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.331943e-01 | 0.135 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.360519e-01 | 0.133 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.377325e-01 | 0.132 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.377325e-01 | 0.132 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.377325e-01 | 0.132 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.377325e-01 | 0.132 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.377325e-01 | 0.132 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.377325e-01 | 0.132 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.377859e-01 | 0.132 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.419380e-01 | 0.130 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.472353e-01 | 0.127 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.473148e-01 | 0.126 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.473148e-01 | 0.126 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.473148e-01 | 0.126 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.532714e-01 | 0.123 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.565475e-01 | 0.121 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.565475e-01 | 0.121 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.644430e-01 | 0.117 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.654434e-01 | 0.116 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.654434e-01 | 0.116 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.654434e-01 | 0.116 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.654434e-01 | 0.116 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.654434e-01 | 0.116 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.654434e-01 | 0.116 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.654434e-01 | 0.116 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.671048e-01 | 0.115 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.734199e-01 | 0.112 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.740147e-01 | 0.111 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.740147e-01 | 0.111 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 7.740147e-01 | 0.111 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.777190e-01 | 0.109 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.822734e-01 | 0.107 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.822734e-01 | 0.107 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.890943e-01 | 0.103 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.902307e-01 | 0.102 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.902307e-01 | 0.102 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.902307e-01 | 0.102 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.906625e-01 | 0.102 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.914755e-01 | 0.102 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.914755e-01 | 0.102 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.972059e-01 | 0.098 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.972059e-01 | 0.098 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.978977e-01 | 0.098 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.978977e-01 | 0.098 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 8.027966e-01 | 0.095 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.052849e-01 | 0.094 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.052849e-01 | 0.094 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.052849e-01 | 0.094 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 8.124025e-01 | 0.090 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.124025e-01 | 0.090 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.124025e-01 | 0.090 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.124025e-01 | 0.090 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.164256e-01 | 0.088 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.192604e-01 | 0.087 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.192604e-01 | 0.087 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.192604e-01 | 0.087 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.192604e-01 | 0.087 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 8.258679e-01 | 0.083 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.258679e-01 | 0.083 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.258679e-01 | 0.083 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.322343e-01 | 0.080 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.322343e-01 | 0.080 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.382316e-01 | 0.077 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.383683e-01 | 0.077 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.383683e-01 | 0.077 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.383683e-01 | 0.077 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.389432e-01 | 0.076 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.405199e-01 | 0.075 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.442784e-01 | 0.074 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.442784e-01 | 0.074 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.442784e-01 | 0.074 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.442784e-01 | 0.074 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.499727e-01 | 0.071 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.499727e-01 | 0.071 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.554592e-01 | 0.068 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.607453e-01 | 0.065 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.658384e-01 | 0.063 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.658384e-01 | 0.063 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.658384e-01 | 0.063 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.678063e-01 | 0.062 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.679068e-01 | 0.062 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.691996e-01 | 0.061 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.707456e-01 | 0.060 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.754735e-01 | 0.058 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.800288e-01 | 0.056 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.814875e-01 | 0.055 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.835878e-01 | 0.054 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.844177e-01 | 0.053 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.844177e-01 | 0.053 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.858008e-01 | 0.053 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.886463e-01 | 0.051 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.923422e-01 | 0.049 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.927205e-01 | 0.049 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.927205e-01 | 0.049 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.943818e-01 | 0.048 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.949160e-01 | 0.048 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.966458e-01 | 0.047 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.985343e-01 | 0.046 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.004278e-01 | 0.046 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.040715e-01 | 0.044 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.040715e-01 | 0.044 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.052450e-01 | 0.043 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.075822e-01 | 0.042 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.075822e-01 | 0.042 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.100577e-01 | 0.041 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.109646e-01 | 0.040 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.125924e-01 | 0.040 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.173631e-01 | 0.037 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.203880e-01 | 0.036 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.203880e-01 | 0.036 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.233024e-01 | 0.035 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.233024e-01 | 0.035 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.261103e-01 | 0.033 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.288156e-01 | 0.032 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.288156e-01 | 0.032 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.302434e-01 | 0.031 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.302434e-01 | 0.031 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.303986e-01 | 0.031 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.314220e-01 | 0.031 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.314220e-01 | 0.031 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.314220e-01 | 0.031 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.314220e-01 | 0.031 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.326843e-01 | 0.030 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.334043e-01 | 0.030 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.339331e-01 | 0.030 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.363524e-01 | 0.029 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.386832e-01 | 0.027 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.409288e-01 | 0.026 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.462520e-01 | 0.024 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.471849e-01 | 0.024 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.471849e-01 | 0.024 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.471849e-01 | 0.024 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.494659e-01 | 0.023 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.509837e-01 | 0.022 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.510034e-01 | 0.022 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.524961e-01 | 0.021 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.553524e-01 | 0.020 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.593294e-01 | 0.018 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.593294e-01 | 0.018 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.593294e-01 | 0.018 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.608199e-01 | 0.017 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.608199e-01 | 0.017 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.631401e-01 | 0.016 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.636393e-01 | 0.016 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.662561e-01 | 0.015 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.662927e-01 | 0.015 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.662927e-01 | 0.015 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.662927e-01 | 0.015 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.684200e-01 | 0.014 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.686849e-01 | 0.014 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.722251e-01 | 0.012 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.737598e-01 | 0.012 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.737598e-01 | 0.012 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.749731e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.749731e-01 | 0.011 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.758911e-01 | 0.011 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.784480e-01 | 0.009 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.792387e-01 | 0.009 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.814411e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.814411e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.814411e-01 | 0.008 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.846057e-01 | 0.007 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.862002e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.918507e-01 | 0.004 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.924386e-01 | 0.003 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.931906e-01 | 0.003 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.946567e-01 | 0.002 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.951184e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.958475e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.960003e-01 | 0.002 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.960572e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.966839e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.968059e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.975434e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.984341e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.985473e-01 | 0.001 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.990022e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.990991e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.992213e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.994928e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.995295e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996162e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.998271e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999341e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999385e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999761e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999931e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999972e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999975e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999977e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999992e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |